Physician profile
Etleva Bejko
NPI 1164804431
$5,066.37
in general payments reported to CMS, 2019-2025
32 companies · $1,619 in 2025
The $1,619 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $15.68 · 2021: $96.87 · 2022: $877 · 2023: $1,068 · 2024: $1,141 · 2025: $1,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,772 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,772.17 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $836.93 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $524.37 | 2021-2025 | Tremfya |
| Amgen INC. | $465.61 | 2021-2025 | Evenity, Otezla, Prolia |
| Aurinia Pharma U.S., INC. | $441.10 | 2022-2025 | Lupkynis |
| Ucb, INC. | $278.43 | 2022-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $245.34 | 2022-2025 | |
| Glaxosmithkline, LLC. | $222.57 | 2022-2025 | Benlysta |
| Astrazeneca Pharmaceuticals Lp | $216.15 | 2022-2024 | Saphnelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.95 | 2022-2025 | Ofev, Spevigo, Cyltezo |
| Depuy Synthes Sales INC. | $196.00 | 2022-2025 | Orthovisc |
| E.R. Squibb & Sons, L.L.C. | $175.15 | 2019-2023 | Sotyktu |
| Janssen Scientific Affairs, LLC | $149.40 | 2024-2025 | Tremfya |
| Mallinckrodt Hospital Products INC. | $146.22 | 2023-2025 | Acthar |
| Radius Health, INC. | $137.48 | 2019-2025 | |
| Genzyme Corporation | $133.72 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $112.95 | 2022-2025 | Taltz, Olumiant, Zepbound |
| Pfizer INC. | $79.65 | 2019-2022 | |
| Genentech USA, INC. | $63.32 | 2019 | |
| Organon LLC | $55.53 | 2023-2024 | Renflexis |
| Horizon Therapeutics Plc | $49.13 | 2019-2023 | Krystexxa |
| Sanofi Pasteur INC. | $48.41 | 2021-2023 | |
| Avanos Medical | $36.01 | 2024-2025 | Trivisc Sodium Hyaluronate |
| Sobi, INC | $31.82 | 2025 | |
| Kyowa Kirin, INC. | $29.47 | 2025 | |
| Zimmer Biomet Holdings, INC. | $29.19 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Almatica Pharma LLC | $29.19 | 2025 | Teriparatide |
| Fresenius Kabi USA, LLC | $27.83 | 2024 | Idacio |
| Kiniksa Pharmaceuticals International, Plc | $23.15 | 2024 | Arcalyst |
| Alvogen INC | $22.50 | 2025 | Teriparatide |
| Ani Pharmaceuticals, INC. | $20.48 | 2025 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $18.30 | 2024 | Strensiq |
| Tonix Medicines, INC. | $18.02 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Etleva Bejko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.